Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Kedudukan dalam Saham #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Harga Saham
$10.35
Modal Pasaran
$6.19B
Perubahan (1 hari)
3.79%
Perubahan (1 tahun)
4.34%
Negara
CN
Perdagangan Gan & Lee Pharmaceuticals. (603087)

Kategori

Sejarah pecahan saham untuk Gan & Lee Pharmaceuticals. (603087)
Saham Gan & Lee Pharmaceuticals. (simbol: 603087) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 26, 2026.
Satu saham 603087 yang dibeli sebelum Aug 26, 2026 kini bersamaan dengan 0 saham 603087.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH